Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 05 09 2018
accepted: 16 11 2018
pubmed: 28 11 2018
medline: 19 11 2019
entrez: 28 11 2018
Statut: ppublish

Résumé

The role of hormonal factors in the etiology of lymphoid neoplasms remains unclear. Previous studies have yielded conflicting results, have lacked sufficient statistical power to assess many lymphoma subtypes, or have lacked detailed information on relevant exposures. Within the European Prospective Investigation Into Cancer and Nutrition cohort, we analyzed comprehensive data on reproductive factors and exogenous hormone use collected at baseline (1992-2000) among 343,458 women, including data on 1,427 incident cases of B-cell non-Hodgkin lymphoma (NHL) and its major subtypes identified after a mean follow-up period of 14 years (through 2015). We estimated hazard ratios and 95% confidence intervals using multivariable proportional hazards modeling. Overall, we observed no statistically significant associations between parity, age at first birth, breastfeeding, oral contraceptive use, or ever use of postmenopausal hormone therapy and risk of B-cell NHL or its subtypes. Women who had undergone surgical menopause had a 51% higher risk of B-cell NHL (based on 67 cases) than women with natural menopause (hazard ratio = 1.51, 95% confidence interval: 1.17, 1.94). Given that this result may have been due to chance, our results provide little support for the hypothesis that sex hormones play a role in lymphomagenesis.

Identifiants

pubmed: 30481275
pii: 5210910
doi: 10.1093/aje/kwy259
pmc: PMC6357796
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-281

Subventions

Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom

Références

J Clin Epidemiol. 2008 Sep;61(9):945-50
pubmed: 18468857
Oncotarget. 2016 Apr 12;7(15):20718-27
pubmed: 26943574
Leukemia. 2011 Jul;25(7):1103-10
pubmed: 21502954
Leuk Lymphoma. 2017 Mar;58(3):528-539
pubmed: 27557932
Int J Cancer. 1993 Jan 21;53(2):215-9
pubmed: 8425757
Ann Oncol. 2012 Sep;23(9):2362-74
pubmed: 22786757
PLoS One. 2009 Dec 02;4(12):e8135
pubmed: 19956586
Int J Cancer. 2011 Aug 15;129(4):974-82
pubmed: 20957632
J Clin Oncol. 2001 Mar 1;19(5):1381-7
pubmed: 11230482
Cancer Causes Control. 2004 May;15(4):419-28
pubmed: 15141141
Am J Epidemiol. 2008 Aug 1;168(3):278-88
pubmed: 18550561
J Pathol. 2006 Feb;208(3):408-14
pubmed: 16294372
J Natl Cancer Inst. 1997 Feb 19;89(4):314-8
pubmed: 9048836
Leuk Lymphoma. 2012 Jan;53(1):139-44
pubmed: 21767241
J Clin Endocrinol Metab. 2007 Aug;92(8):3040-3
pubmed: 17519304
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):217-21
pubmed: 26464426
Ann Oncol. 2013 Feb;24(2):433-41
pubmed: 22967995
Cancer Causes Control. 2010 Dec;21(12):2079-83
pubmed: 20697798
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6694-9
pubmed: 12740446
Crit Rev Oncol Hematol. 2014 Dec;92(3):181-93
pubmed: 25132165
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44
pubmed: 25174034
Am J Epidemiol. 2004 Oct 15;160(8):766-73
pubmed: 15466499
Swiss Med Wkly. 2010 Apr 3;140(13-14):187-201
pubmed: 20175004
Cancer Causes Control. 2013 Jul;24(7):1279-89
pubmed: 23568533
Ann N Y Acad Sci. 2010 Apr;1193:36-42
pubmed: 20398006
Stat Med. 2016 Feb 28;35(5):782-800
pubmed: 26619806
Ann Intern Med. 2002 Aug 20;137(4):273-84
pubmed: 12186518
Neoplasma. 1990;37(2):185-90
pubmed: 2342631
Cancer Res. 1992 Oct 1;52(19 Suppl):5510s-5515s
pubmed: 1394165
Cancer Causes Control. 2002 Mar;13(2):131-6
pubmed: 11936819
Exp Hematol. 2017 May;49:34-38.e2
pubmed: 28115200
Int J Cancer. 1997 Jan 17;70(2):155-8
pubmed: 9009153
Leuk Res. 1997 Sep;21(9):885-8
pubmed: 9393604
Am J Epidemiol. 2018 Aug 1;187(8):1630-1641
pubmed: 29394309
Int J Cancer. 2016 Feb 1;138(3):604-11
pubmed: 26365326
Leuk Lymphoma. 2013 Apr;54(4):720-5
pubmed: 22916741
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Cancer Causes Control. 2003 Sep;14(7):639-44
pubmed: 14575361
J Chronic Dis. 1980;33(10):595-605
pubmed: 7410520
Cancer Causes Control. 2012 Jan;23(1):195-206
pubmed: 22116538
Hum Reprod Update. 2005 Jul-Aug;11(4):411-23
pubmed: 15817524
Br J Haematol. 2010 Mar;148(5):739-53
pubmed: 19958356
Br J Cancer. 2006 May 8;94(9):1339-41
pubmed: 16670705
Int J Epidemiol. 1994 Aug;23(4):691-9
pubmed: 8002181
J Clin Endocrinol Metab. 2005 Jul;90(7):3847-53
pubmed: 15827095
Int J Cancer. 2009 Jun 1;124(11):2737-43
pubmed: 19253366
Eur J Epidemiol. 2006;21(9):673-9
pubmed: 17048087

Auteurs

Laura Costas (L)

Unit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.

Leila Lujan-Barroso (L)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
Department of Nursing of Public Health, Mental Health and Maternity and Child Health, School of Nursing, Universitat de Barcelona, Barcelona, Spain.

Yolanda Benavente (Y)

Unit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.

Naomi E Allen (NE)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Pilar Amiano (P)

Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Public Health Division of Gipuzkoa, BioDonostia Health Research Institute, San Sebastian, Spain.

Eva Ardanaz (E)

Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.

Caroline Besson (C)

Unit of Hematology-Oncology, Centre Hospitalier de Versailles, Le Chesnay, France.
Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine-Université Paris-Sud and Faculté de Médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France.
Institut Gustave Roussy, Villejuif, France.

Heiner Boeing (H)

German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Bas Bueno-de-Mesquita (B)

Department of Determinants of Chronic Diseases, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, the Netherlands.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St. Mary's Campus, London, United Kingdom.
Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Iris Cervenka (I)

Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine-Université Paris-Sud and Faculté de Médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France.
Institut Gustave Roussy, Villejuif, France.

Renée T Fortner (RT)

Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.

Agnès Fournier (A)

Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine-Université Paris-Sud and Faculté de Médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France.
Institut Gustave Roussy, Villejuif, France.

Marc Gunter (M)

International Agency for Research on Cancer, Lyon, France.

Sophia Harlid (S)

Department of Radiation Sciences, Oncology, Faculty of Medicine, Umeå University, Umeå, Sweden.

José María Huerta (JM)

Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, Instituto Murciano de Investigación Biosanitaria-Arrixaca, Murcia, Spain.

Mats Jerkeman (M)

Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.

Karin Jirström (K)

Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
Department of Pulmonary Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University General Hospital, Haidari, Greece.

Kay-Tee Khaw (KT)

Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Anastasia Kotanidou (A)

Hellenic Health Foundation, Athens, Greece.
Department of Critical Care Medicine and Pulmonary Services, University of Athens Medical School, Evangelismos Hospital, Athens, Greece.

Eiliv Lund (E)

Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.

Amalia Mattiello (A)

Dipartimento di Medicina Clinica e Chirugia, Federico II University, Naples, Italy.

Beatrice Melin (B)

Department of Radiation Sciences, Oncology, Faculty of Medicine, Umeå University, Umeå, Sweden.

Virginia Menéndez (V)

Public Health Directorate, Asturias, Spain.

Neil Murphy (N)

International Agency for Research on Cancer, Lyon, France.

Alexandra Nieters (A)

Center for Chronic Immunodeficiency at the Center for Translational Cell Research, University of Freiburg Medical Center, Freiburg, Germany.

Kim Overvad (K)

Department of Public Health, Faculty of Health, Aarhus University, Aarhus, Denmark.

Elio Riboli (E)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention, Turin, Italy.

Maria-Jose Sánchez (MJ)

Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria de Granada, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

Julie A Schmidt (JA)

Cancer Epidemiology Unit, Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Sabina Sieri (S)

Epidemiology and Prevention Unit, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milano, Italy.

Anne Tjønneland (A)

Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Maria Paternò Arezzo Hospital, Ragusa, Italy.

Roel Vermeulen (R)

Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Elisabete Weiderpass (E)

Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.
Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland.
Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Silvia de Sanjosé (S)

PATH, Seattle, Washington.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.

Delphine Casabonne (D)

Unit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH